Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2022
14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancerLidija A Wilhelms Garan, Yang Xiao, Weei-Chin LinCommunications Biology|November 5, 2025
Mutant p53 variants differentially impact replication initiation and activate cGAS-STING to affect immune checkpoint inhibitionKang Liu, Lidija A Wilhelms Garan, Fang-Tsyr Lin, et al.Circulation. Cardiovascular Quality and Outcomes|July 30, 2015
Content Analysis of Social Media Related to Left Ventricular Assist DevicesKristin M Kostick, Jennifer S Blumenthal-Barby, Lidija A Wilhelms, et al.Cancer Research Communications|September 27, 2023
DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP InhibitorsHelena Folly-Kossi, Joshua D Graves, Lidija A Wilhelms Garan, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 31, 2017
Patients' Perspectives on Transplantation While Undergoing Left Ventricular Assist Device SupportLidija A Wilhelms, Jennifer S Blumenthal-Barby, Kristin M Kostick, et al.Proceedings of the National Academy of Sciences of the United States of America|October 25, 2023
A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitorsFang-Tsyr Lin, Kang Liu, Lidija A Wilhelms Garan, et al.Journal of Cardiac Failure|June 27, 2015
Reasons Why Eligible Candidates Decline Left Ventricular Assist Device PlacementCourtenay R Bruce, Kristin M Kostick, Estevan D Delgado, et al.Pageof 1